Hearts and Minds Investments Outperforms Market
Company Announcements

Hearts and Minds Investments Outperforms Market

Hearts and Minds Investments Ltd (AU:HM1) has released an update.

Hearts and Minds Investments Ltd reported a strong performance with their portfolio up 4.6% in July, outpacing the MSCI World Index, and delivering a 10% annualized pre-tax investment return since inception in November 2018. The company highlighted a fully franked dividend yield of 5.1% and a post-tax NTA of $3.15, while also announcing significant developments for Telix Pharmaceuticals, including an upgraded revenue forecast and progress with FDA applications. Despite market concerns over AI overinvestment and the potential for a tougher economic soft landing, the investment firm remains ahead with cumulative medical research funding reaching $48.9 million.

For further insights into AU:HM1 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App